HC Wainwright & Co. reiterated coverage on Kezar Life Sciences with a new price target

11/16/21 9:44:47 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Kezar Life Sciences with a rating of Buy and set a new price target of $20.00 from $12.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$KZR

Date	Price Target	Rating	Analyst
8/11/2023	$4.00	Overweight → Equal Weight	Wells Fargo
3/16/2023		Outperform → Mkt Perform	William Blair
12/8/2021	$19.00	Overweight	Wells Fargo
11/16/2021	$12.00 → $20.00	Buy	HC Wainwright & Co.
7/20/2021	$14.00	Buy	JonesTrading